Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus

Oncology Today with Dr Neil Love · Sep 11, 2026 · 59m

Featuring an interview with Prof Andreas Hochhaus, including the following topics:

Biology of chronic myeloid leukemia (CML) and rationale for current therapeutic approaches; importance of cytogenetic testing (0:00)

Mechanistic differences among first-generation tyrosine kinase inhibitors (TKIs), second-generation TKIs and asciminib (6:09)

Potential mechanisms of adverse events documented with TKIs (10:23)

Recent survey of patients with CML regarding goals of therapy and clinical implications; considerations for discontinuation of therapy (16:23)

Comparative tolerability of asciminib and…